Methyl 2-(4-oxopiperidin-1-yl)acetate

Catalog No.: 
ACEIJF059
CAS No.: 
202197-70-4
Molecular Formula: 
C8H13NO3
Molecular Weight: 
171.20
Methyl 2-(4-oxopiperidin-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$67.00In stockIn stock
1g95%$177.00In stockIn stock
5g95%$726.00In stockIn stock
25g95%$2643.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(4-oxopiperidin-1-yl)acetate
IUPAC Namemethyl 2-(4-oxopiperidin-1-yl)acetate
MDL No.MFCD09936134
Molecular FormulaC8H13NO3
Molecular Weight171.20
SMILESO=C(OC)CN1CCC(CC1)=O
InChI KeyWWLVHJAXNZPGGB-UHFFFAOYSA-N
SynonymMethyl 2-(4-oxopiperidin-1-yl)acetate;1-Piperidineacetic acid, 4-oxo-, methyl ester
CAS No.202197-70-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEIJF059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIJF059 route product structure diagram
    ACEIJF059202197-70-4In Stock
Inquiry

2. ACEIJF059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIJF059 route product structure diagram
    ACEIJF059202197-70-4In Stock
Inquiry

3. ACEIJF059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIJF059 route product structure diagram
    ACEIJF059202197-70-4In Stock
Inquiry

Comments (0)